NCT04079959

Brief Summary

Uterine natural killer (uNK) cells have been implicated to play a role in female reproductive performance. Serval studies showed an increased uNK cell density in the endometrium of women with reproductive failure. In this study, we wish to investigate the density and clustering of four different immune cells.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 6, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

September 15, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 23, 2020

Status Verified

January 1, 2020

Enrollment Period

3.3 years

First QC Date

August 27, 2019

Last Update Submit

January 21, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • immune cell counting

    The counting method will be performed according to an agreed and published standardized protocol by a multicenter working group designed to reduce variance of results between centres. Ten images of 40X magnification fields will be analyzed for each sample. The first field to be captured should be selected at random, ensuring that it contained the luminal epithelial border. Subsequent fields should be obtained by moving one field to the left or right of the original field, keeping the luminal epithelial border in view.

    up to 2 months

  • Quantification of endometrial immune cells spatial distribution

    In each 200 times under the microscope vision, based on the X and Y position of each single cell which InForm system could provide, the relative spatial distribution of each individual endometrial immune cell will be considered as a bivariate point pattern

    up to 2 months

Study Arms (1)

women who are undergoing frozen embryo transfer

endometrial biopsy will be done one cycle before the frozen embryo transfer

Procedure: endometrial biopsy

Interventions

. Endometrial samples are obtained using a biopsy catheter as follows: the Pipette is inserted through the cervical os and advanced gently until resistance is felt. The inner piton of the device is then withdrawn to create suction, and the endometrial sample is obtained by moving the pipette up and down approximately 2-3 cm within the uterine cavity. The device is rotated 360° to ensure adequate coverage of the area.

women who are undergoing frozen embryo transfer

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEndometrial biopsies will be collected for all the participants
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women undergoing frozen embryo transfer.

You may qualify if:

  • Women undergoing frozen embryo transfer.

You may not qualify if:

  • Women older than 40 years
  • Women who have any uterine anomaly or intrauterine pathology such as:
  • Endometrial polyp or/ and Large fibroid with a diameter \>4 cm
  • Visible hydrosalpinx on transvaginal ultrasound scans
  • BMI \>35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

endometrial samples will be stored

Study Officials

  • Xiaoyan Chen, PhD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wing Ching Cheung, PhD

CONTACT

Xiaoyan Chen, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

August 27, 2019

First Posted

September 6, 2019

Study Start

September 15, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2023

Last Updated

January 23, 2020

Record last verified: 2020-01

Locations